UroGen Pharma Ltd.

URGN

—

Advanced chart & tools →

UroGen Pharma Ltd.URGN

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-4.96

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$109.79M

Net income

$-153.49M

Net margin

-139.8%

Gross margin

88.7%

Dividends & financials

UroGen Pharma Ltd. (URGN) reported revenue of $109.79M and net income of $-153.49M, or $-4.96 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.